Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD28null pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death.
Pera A, Caserta S, Albanese F, Blowers P, Morrow G, Terrazzini N, Smith HE, Rajkumar C, Reus B, Msonda JR, Verboom M, Hallensleben M, Blasczyk R, Davies KA, Kern F. Pera A, et al. Among authors: verboom m. Theranostics. 2018 Aug 7;8(16):4509-4519. doi: 10.7150/thno.27428. eCollection 2018. Theranostics. 2018. PMID: 30214635 Free PMC article.
Sequence analysis of the novel allele HLA-B*070502.
Horn PA, Verboom M, Blasczyk R. Horn PA, et al. Among authors: verboom m. Tissue Antigens. 2006 Mar;67(3):251-3. doi: 10.1111/j.1399-0039.2006.00546.x. Tissue Antigens. 2006. PMID: 16573566 No abstract available.
CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.
Sukdolak C, Tischer S, Dieks D, Figueiredo C, Goudeva L, Heuft HG, Verboom M, Immenschuh S, Heim A, Borchers S, Mischak-Weissinger E, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Sukdolak C, et al. Among authors: verboom m. Biol Blood Marrow Transplant. 2013 Oct;19(10):1480-92. doi: 10.1016/j.bbmt.2013.07.015. Epub 2013 Jul 23. Biol Blood Marrow Transplant. 2013. PMID: 23891747 Free article.
IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.
Ius F, Sommer W, Kieneke D, Tudorache I, Kühn C, Avsar M, Siemeni T, Salman J, Erdfelder C, Verboom M, Kielstein J, Tecklenburg A, Greer M, Hallensleben M, Blasczyk R, Schwerk N, Gottlieb J, Welte T, Haverich A, Warnecke G. Ius F, et al. Among authors: verboom m. Transplantation. 2016 Dec;100(12):2682-2692. doi: 10.1097/TP.0000000000001027. Transplantation. 2016. PMID: 26714123 Free PMC article.
Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation.
Ius F, Verboom M, Sommer W, Poyanmehr R, Knoefel AK, Salman J, Kuehn C, Avsar M, Siemeni T, Erdfelder C, Hallensleben M, Boethig D, Schwerk N, Mueller C, Welte T, Falk C, Haverich A, Tudorache I, Warnecke G. Ius F, et al. Among authors: verboom m. Am J Transplant. 2018 Sep;18(9):2295-2304. doi: 10.1111/ajt.14912. Epub 2018 Jun 3. Am J Transplant. 2018. PMID: 29719115 Free PMC article.
54 results